Refine Search
(0)
(0)
(3)
(5)

Urological Cancers

GlobalData’s coverage of the urological cancers space includes in-depth market analyses and drug sales forecasts for both Bladder and Prostate Cancers along with Epidemiology reports and forecasts for these indications. This series of reports provides expert-driven insight on the current and future treatment landscape, key unmet needs, and opportunities to compete in the market for Bladder and Prostate cancers.

Bladder Cancer: Dynamic Market Forecast to 2026

  • $8,495
  • March 2018
Add to Basket Quick View Add to Saved List

Bladder cancer is a rapidly evolving field in which new developments are constantly influencing the market landscape.

The Dynamic Market Forecast is designed to help clients stay abreast of the latest news in the bladder cancer space, in...

PharmaPoint: Prostate Cancer - Global Drug Forecast and Market Analysis to 2026

  • $10,995
  • November 2017
Add to Basket Quick View Add to Saved List

The prostate cancer market is expected to experience a moderate growth between 2016 and 2026. The main drivers of growth will be the expected label expansion of second-generation hormonal agents into hormone-sensitive disease and non-metastatic...

EpiCast Report: Prostate Cancer – Epidemiology Forecast to 2026

  • $3,995
  • November 2017
Add to Basket Quick View Add to Saved List

Prostate cancer is a malignancy in the prostate gland, which is located below the bladder and in front of the rectum in males. Worldwide, about 1.1 million men were diagnosed with prostate cancer in 2012. Diagnosed incident cases of prostate ca...

OpportunityAnalyzer: Bladder Cancer – Opportunity Analysis and Forecasts to 2025

  • $10,995
  • April 2017
Add to Basket Quick View Add to Saved List

The bladder cancer market in the seven major pharmaceutical markets (US, France, Germany, Italy, Spain, UK, and Japan) has remained largely unchanged in the past 10-20 years. However, significant expansion is expected starting in 2016, with the...

EpiCast Report: Bladder Cancer - Epidemiology Forecast to 2025

  • $3,995
  • December 2016
Add to Basket Quick View Add to Saved List

Bladder cancer is a commonly diagnosed cancer and causes significant numbers of cancer deaths worldwide. The major risk factors for bladder cancer are exposure to smoking and occupational risk factors such as exposure to aromatic amines. These ...